Protagonist Therapeutics, Inc - Common Stock (PTGX)

CUSIP: 74366E102

Q4 2021 13F Holders as of 31 Dec 2021

Holder snapshot 7 signals
Share change
+2,357,782
Put/Call ratio
53%
SEC-reported price per share
$34.20
Number of holders
144
Value change
+$93,460,895
Number of buys
84
Open additional details 1 more signal available
Number of sells
51
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
64,698,329

Security key

74366E102

Report period

Q4 2021

Institutions

144

Top holders

10

Ownership snapshot

Top reported holders of PTGX - Protagonist Therapeutics, Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
30 Sep 2021
13F Highest disclosed value: $115,049,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FMR LLC has the largest disclosed position value at $115.05M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Disclosed position value Top 5
FMR LLC $115.05M
Point72 Asset Management, L.P. $77.74M
BVF INC/IL $69.14M
BlackRock Finance, Inc. $56.7M
JOHNSON & JOHNSON $43.4M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F
Company
13F
—
denominator unverified
$115,049,000
6,492,638 shares
— 30 Sep 2021
Point72 Asset Management, L.P.
13F
Company
13F
—
denominator unverified
$77,743,000
4,387,300 shares
— 30 Sep 2021
BVF INC/IL
13F
Company
13F
—
denominator unverified
$69,139,000
3,901,759 shares
— 30 Sep 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$56,695,000
3,199,496 shares
— 30 Sep 2021
JOHNSON & JOHNSON
13F
Company
13F
—
denominator unverified
$43,400,000
2,449,183 shares
— 30 Sep 2021
FARALLON CAPITAL MANAGEMENT, L.L.C.
13F
Company
13F
—
denominator unverified
$42,386,000
2,392,000 shares
— 30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
144
Shares
49,204,800
Rows available
144
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
126
Q4 2021 holders
144
Holder diff
18
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 value Q4 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .